Use and determinants of the methylprednisolone protocol for traumatic spinal cord injury in south carolina acute care hospitals

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 5, 2009, Pages 1446-1450

  Nicholas, Joyce S ^a,b   Selassie, Anbesaw W ^a   Lineberry, Lee A ^a   Pickelsimer, E Elisabeth ^a   Haines, Stephen J ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Memylprataisolone; Methylprednisolone protocol; Spinal cord injury

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG UTILIZATION; EMERGENCY CARE; FEMALE; HEALTH SURVEY; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HUMAN; INFANT; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; SPINAL CORD INJURY; THORAX INJURY; UNITED STATES; ACUTE DISEASE; BLUNT TRAUMA; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; EMERGENCY HEALTH SERVICE; HEALTH CARE DELIVERY; HOSPITAL; INJURY SCALE; MIDDLE AGED; PENETRATING TRAUMA; PRACTICE GUIDELINE; PROBABILITY; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, SPECIAL; HUMANS; INJURY SEVERITY SCORE; LOGISTIC MODELS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPROTECTIVE AGENTS; PRACTICE GUIDELINES AS TOPIC; PROBABILITY; QUESTIONNAIRES; RISK ASSESSMENT; SOUTH CAROLINA; SPINAL CORD INJURIES; TREATMENT OUTCOME; WOUNDS, NONPENETRATING; WOUNDS, PENETRATING; YOUNG ADULT;

EID: 67649635408     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318190bf49     Document Type: Article

References (16)

1. National Spinal Cord Injury Statistical Center (NSCISC), University of Alabama at Birmingham. Spinal Cord Injury Facts and Figures at a Glance-June 2005. Available at www.spinalcord.uab.edu. Accessed March 30, 2006.
2. National Center for Injury Prevention and Control (NCIPC). Injury Fact Book 2001-2002. Atlanta, GA: Centers for Disease Control and Prevention; 2001.
3. Selassie AW. South Carolina Head and Spinal Cord Injury Information System, Annual Report. Columbia, SC: Department of Disabilities and Special Needs; 2001.
4. McCutcheon E, Selassie AW, Gu J, Pickelsimer EE. Acute traumatic spinal cord injury 1993-2000: a population-based assessment of methylprednisolone (MPSS) administration and hospitalization. J Trauma. 2004;56:1076-1083.
5. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405-1411.
6. Bracken MB. Treatment of acute spinal cord injury with methylprednisolone: Results of a multicenter, randomized clinical trial. J Neurotrauma. 1991;8:S47-S52.
7. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow- up data: Results of the second National Acute Spinal Cord Injury Study. J Neurosurg. 1992;76:23-31.
8. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg. 1993;79:500-507.
9. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA. 1997;277:1597-1604.
10. Bracken MB, Shepard MJ; Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. J Neurosurg. 1998;89:699-706.
11. Bracken MB, Aldrich EF, Herr DL, et al. Clinical measurement, statistical analysis, and risk-benefit: controversies from trials of spinal injury. J Trauma. 2000;48:558-561.
12. Bracken MB. Pharmacological interventions for acute spinal cord injury. Cochrane Database Syst Rev. 2001;1:1-32.
13. Joint Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery. 2002;50(3 suppl):S63-S72.
14. Thurman DJ, Snieznek JE, Johnson D, et al. Guidelines for Survellance of Central Nervous System Injury. Atlanta, GA: Centers for Disease Control and Prevention; 1995.
15. Vellman WP, Hawkes AP, Lammertse DP. Administration of corticosteroids for acute spinal cord injury. Spine. 2003;28:941-947.
16. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg. 2000;93(l suppl):l-7.